Aerie Pharmaceuticals, Inc
AERI NASDAQ

AERI
Aerie Pharmaceuticals, Inc NASDAQ
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now

Financial statements

Aerie Pharmaceuticals, Inc key financial stats and ratios

AERI price-to-sales ratio is 8.30. The company has an Enterprise Value to EBITDA ratio of -5.34. As of 2020 they employed 365.00 people.

Current
Key stats
Total common shares outstanding
Float shares outstanding
Number of employees
Number of shareholders
Valuation ratios
Price to earnings ratio
Price to sales ratio
Price to cash flow ratio
Price to book ratio
Enterprise value
Enterprise value to EBITDA ratio
Profitability ratios
Return on assets %
Return on equity %
Return on invested capital %
Gross margin %
Operating margin %
EBITDA margin %
Net margin %
Liquidity ratios
Quick ratio
Current ratio
Inventory turnover
Asset turnover
Solvency ratios
Debt to assets ratio
Debt to equity ratio
Long term debt to total assets ratio